Scarica l'app Stockscreener
493.76
0.68%
2.42
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VRTX Giù?
Forum
Previsione
Frazionamento azionario
Vertex Pharmaceuticals Inc Borsa (VRTX) Ultime notizie
Vertex Pharma enters Russell 1000 value, shares reflect mixed benchmark shift - AD HOC NEWS
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) added to Russell 1000 Value Benchmark - marketscreener.com
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Vertex Pharmaceuticals Incorporated(NasdaqGS:VRTX) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
Vertex Pharma analyst optimism builds ahead earnings week, shares trade near recent high - Ad-hoc-news.de
Price to book forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Price to earnings forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Vertex Pharma strategy in cystic fibrosis, shares anchored in the NASDAQ-100 healthcare field - Ad-hoc-news.de
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 26 June - Investing.com UK
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 26 June By Investing.com - Investing.com South Africa
Enterprise value to EBIT forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Price to sales forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
VRTX (NASDAQ) affiliate files Form 144: 596 shares vest, multiple sales by Carmen R. Bozic - Stock Titan
Enterprise value to revenue forward of Vertex Pharmaceuticals Incorporated – NASDAQ:VRTX - TradingView
Vertex Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:VRTX) - TradingView
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
Vertex Pharma leads biotech this week, shares hover near record highs - Ad-hoc-news.de
Fierce Biotech Layoff Tracker 2026: Biogen sheds Apellis R&D roles; ADC Tx slims workforce - Fierce Biotech
Vertex Pharmaceuticals Incorporated Actuals & Estimates (BMV:VRTX) - TradingView
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why Vertex Pharmaceuticals (NASDAQ:VRTX) Is Drawing Fresh Attention? - Kalkine Media
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade) (VRTX) - Seeking Alpha
Is Vertex Pharmaceuticals Successfully Diversifying Beyond Cystic Fibrosis - Kavout | AI
Former Vertex, GSK exec launches science-first pet nutrition company - The Business Journals
Vertex Pharmaceuticals Inc (VRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form - The New York Times
Vertex (VRTX) EVP and CMO Carmen Bozic sells 1,020 shares under 10b5-1 plan - Stock Titan
Vertex Pharma with clear analyst backing, shares supported by strong consensus estimates - Ad-hoc-news.de
Vertex Pharmaceuticals (VRTX) Stock After Strong Multi‑Year Run Is The Price Still Reasonable - Yahoo Finance
Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX) - Yahoo Finance
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda - GlobeNewswire Inc.
Vertex Pharmaceuticals (NASDAQ:VRTX): A GARP Growth Stock with Reasonable Valuation and Strong Fundamentals - ChartMill
Vertex Pharmaceuticals Inc (VRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vertex Pharmaceuticals Inc (VRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 3.45% on Jun 22: What Signal Does It Send? - TradingKey
2 Reasons to Like VRTX (and 1 Not So Much) - Yahoo Finance
Barclays Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $615 - Moomoo
How Strong Pediatric CASGEVY Data Could Impact Vertex Pharmaceuticals’ (VRTX) Gene Therapy Investment Narrative - simplywall.st
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up. Here's What That Means for Both Stocks. - The Motley Fool
Vertex Pharma Stockweekly review in a strong biotech sector - Ad-hoc-news.de
Can Vertex's Kidney Pipeline Power Its Next Growth Phase? - TradingView
Nia Impact Solutions Fund's Vertex Pharmaceuticals Inc(VRTX) Holding History - GuruFocus
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock - Yahoo Finance
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Vertex Pharmaceuticals CFO’s case for thinking like a portfolio manager - CFO.com
Citi Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $585 - Moomoo
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):